Treatment of Cortical Myoclonus With Repetitive Transcranial Magnetic

Status Completed

Clinical Trial Summary

Myoclonus is a condition related to epilepsy of involuntary twitching or jerking of the limbs.

The purpose of this study is to determine if stimulation of the brain with magnetic pulses can decrease myoclonus. Researchers believe that this may be possible because in studies on normal volunteers, magnetic stimulation made areas of the brain difficult to activate for several minutes. In addition, early studies on patients with myoclonus have shown magnetic stimulation to be effective at decreasing involuntary movements.

Transcranial Magnetic Stimulation (TMS) is a non-invasive technique that can be used to stimulate brain activity and gather information about brain function. It is very useful when studying the areas of the brain and spinal cord related to motor activity (motor cortex and corticospinal tract). Repetitive transcranial magnetic stimulation (rTMS) involves the placement of coil of wire (electromagnet) on the patient's scalp and rapidly turning on and off the electrical current. The changing magnetic field produces weak electrical currents in the brain near the coil. This permits non-invasive, relatively localized stimulation of the surface of the brain (cerebral cortex). The effect of magnetic stimulation varies, depending upon the location, intensity and frequency of the magnetic pulses.

Researchers plan to use rTMS for 10 days on patients participating in the study. The 10 day period will be broken into 5 days of active repetitive magnetic stimulation and 5 days of placebo "ineffective" stimulation. At the end of the 10 day period, if the results show that rTMS was beneficial, patients may undergo an additional 5 days of active rTMS.

Clinical Trial Description

Repetitive transcranial magnetic stimulation (rTMS) at frequencies in the single Hz range causes a decrease in the excitability of the primary motor cortex and there is preliminary evidence that it can suppress abnormal excess cortical activity. We plan to test 1 Hz rTMS as treatment for cortical myoclonus. ;

Study Design

Endpoint Classification: Safety Study, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00001663
Study type	Interventional
Source	National Institutes of Health Clinical Center (CC)
Contact
Status	Completed
Phase	Phase 1
Start date	January 1997
Completion date	January 2002

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT00018889` - Phenotype/Genotype Correlations in Movement Disorders
Completed	`NCT02160886` - Effects of a Task Oriented Intervention With Two Goal-setting Approaches	N/A
Completed	`NCT00001549` - Diagnosis and Natural History Study of Patients With Neurological Conditions	N/A
Completed	`NCT00001361` - Magnetic Resonance Imaging Studies of Motor and Thought Processes	N/A
Recruiting	`NCT05413291` - Natural History Protocol for Movement Disorders
Completed	`NCT02938754` - Rehabilitation Gaming System for Cerebral Palsy	N/A
Completed	`NCT02699398` - Domiciliary VR Rehabilitation	N/A
Recruiting	`NCT00331669` - Efficacy and Safety of Deep Brain Stimulation (DBS) of the Pallidal (GPi) in Patients With Tardive Dystonia	Phase 2
Completed	`NCT00105131` - Genetic Characterization of Parkinson's Disease	N/A
Completed	`NCT00001324` - PET Scan to Study Brain Control of Human Movement
Recruiting	`NCT00001252` - Human Movement Database
Completed	`NCT00610233` - Effect of Deep Brain Stimulation on Lower Urinary Tract Function	N/A
Completed	`NCT00017966` - Brain Excitability During Self-Paced Voluntary Movements	N/A
Completed	`NCT00017979` - Study of Brain Control of Movement	N/A
Completed	`NCT00118586` - Neuropathology of Spasmodic Dysphonia
Recruiting	`NCT02014246` - Genetic Characterization of Movement Disorders and Dementias
Completed	`NCT00001780` - Magnetic Stimulation of the Human Nervous System	N/A
Recruiting	`NCT02588638` - Next Generation Sequencing Diagnostics - On the Road to Rapid Diagnostics for Rare Diseases
Completed	`NCT01037361` - Cerebral Activity Related to Primary Motor Stereotypies in Children: An EEG Study.
Completed	`NCT02689466` - Cholinergic Receptor Imaging in Dystonia

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Treatment of Cortical Myoclonus With Repetitive Transcranial Magnetic Stimulation

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms